23 November 2017
News and Views
Links and Services
This month's issue of the Inflammatory Bowel Disease investigates the outcome of pregnancy in women with IBD receiving antitumor necrosis factor therapy.
Infliximab and adalimumab are attractive treatment options in patients with inflammatory bowel di
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors